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Ginseng, the root of the Panax genus plant has been used 
as an herbal medicine in Asia for over two thousand years 
for its various health benefits including (but not limited 
to)antioxidant, anti-carcinogenic, anti-inflammatory, 
antihypertensive andanti-diabetic effects. The 
pharmacologically active compounds behind the claims of 
ginseng’s efficacy are ginsenosides. More than 300 
different ginsenosides have been identified from several 
Panax plants. Ginsenoside is triterpene glycoside with four 
rings and several sugar moieties; they are found 
exclusively in ginseng plants and are in higher 
concentration in their roots. 
Qualitative and quantitative techniques for the analysis of 
ginsenosides are in demand to ensure quality control of 
ginseng. Korean Pharmacopeia (KP) and Japanese 
Pharmacopeia (JP) describe ginseng as it contains not less 
than 0.10% of ginsenoside Rg1 and not less than 0.20% of 
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ginsenoside Rb1. Chinese Pharmacopeia (CP) describes 
that ginseng should contains not less than 0.30% of 
Rg1+Re and not less than 0.20% of Rb1.This kind of 
standard is appropriate for the quality control of white 
ginseng and its powder. However, that most ginsenoside 
lose a part of its sugar moiety and transformed to less 
polar ginsenoside especially under the heat, in acidic 
condition, or by fermentation. Heating process converts 
the naturally occurring ginsenoside Rg1 and Rb1 into 
artifact ginsenosides such as gisenosides Rg3, Rg5, Rh1, 
and Rh2. Therefore, gisenoside Rg1 and Rb1 which have 
been used as quality markers of ginseng, do not express 
the quality of some ginseng products. Consequently, the 
official method for the quality control of ginseng is not 
applicable for the processed ginseng. 
The aim of this study is to develop a new simple analytical 
method which can be applied to all kinds of ginseng 
products including processed ginseng. To achieve this goal, 
sample preparation method and analytical condition were 
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optimized using design of experiment (DOE) technique. 
The optimal conditions for the extraction of Rg1 and Rb1, 
which are the major compounds for White ginseng and Red 
ginseng were found at 60% aqueous methanol. However, 
80% aqueous methanol was better for the efficient 
extraction of ginsenoside Rk1 and Rg5. The result 
indicates that the less polar solvent system might be a 
better choice for the efficient extraction of a ginseng 
preparation containing a large amount of ginsenoside Rk1 
and Rg5.In general, 70% aqueous methanol was superior 
to 60% or 80% methanol for the extraction of polar and 
less polar ginsenosides together. The coefficient of 
correlation (R2) was higher than 0.994 for all calibration 
curves. The method sensitivity was measured in terms of 
the limit of detection (LOD), which ranged from 1-7 ng/ml. 
The limit of quantification (LOQ) was found 2-23 ng/ml. 
Ginsenoside Rb1 and Rg1 are described in Pharmacopeia 
as the marker compounds for the quality control of 
ginseng. However, they are not adequate marker for the 
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certain ginseng products as they are unstable and easily 
convert to less polar ginsenosides. To solve this problem, 
group quantitation of ginsenoside was applied. All kinds of 
ginsenosides were categorized into three groups as 
follows. Group A: protopanaxatriol (PPT) group includes 
Rg1 and Re; Group B: protopanaxadiol (PPD) group 
includes Rb1, Rb2, Rc and Rd; Group C: less polar 
ginsenosides group includes Rg3, Rk1 and Rg5. The 
contents of ginsenosides in Group A, B and C were 
expressed as the contents of ginsenosides Rg1, Rb1, and 
Rg3, respectively. The group quantitation method was 
successfully applied for the quantitative analysis of White 
ginseng and heat-treated ginseng products. The contents 
of ginsenoside Rg1 and Rb1 in White ginseng were 0.37 
mg/g and 1.41mg/g, respectively. The content of PPT 
group and PPD group in the same sample were 1.23 mg/g 
and 3.91mg/g, respectively which gives better information 
about the total content of ginsenosides and, consequently, 
quality of ginseng. Sum of all ginsenosides was 5.14 mg/g. 
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Due to the steaming process the contents of ginsenoside 
Rg1 (0.08 mg/g) and Rb1 (0.78 mg/g) in processed 
ginseng were degraded, which does not meet the 
requirements of the Pharmacopoeia. The content of group 
analysis in the same sample was as follows: 0.38 mg/g for 
PPT group, 3.16 mg/g for PPD group and 1.90 mg/g for 
less polar gisenosides group.  Sum of all ginsenosides 
was 5.44 mg/g. 
Group analysis method is applicable not only White and 
Red ginseng but also other processed ginseng. 
Furthermore it gives more information about the quality of 
ginseng products.  
High performance liquid chromatography (HPLC) with 
evaporative light scattering detection (ELSD) and 
quadrupole time-of-flight mass spectrometry (Q-TOF-
MS) were used for qualitative and quantitative analysis of 
ginsenosides in wild Panax species, namely Panax ginseng, 
Panax quinquefolius and Panax vietnamensis. Identification 
of ginsenosides was achieved using Q-TOF-MS and 
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contents were determined by ELSD.  
The contents of 17 ginsenosides were determined by LC-
ELSD. Among them 11 ginsenosides were identified using 
standards. Those were  notoginsenoside R1, majonoside 
R1, ginsenoside Rg1, ginsenoside Re, majonoside R2, 
vina-ginsenoside R2, notoginsenoside R2, ginsenoside 
Rb1, ginsenoside Rc, ginsenoside Rb2, and ginsenoside Rd. 
To identify six other unidentified metabolites, m/z of [M-
H] - and fragment ions were measured by LC-Q-TOF-
MS and compared to literature values. Total content of 
ginsenosides in the radix and rhizome of wild 
P.vietnamensis were 111.06 and 84.44 mg/g, respectively. 
Total content of ginsenosides in the radix and rhizome of 
P. ginseng were 10.17 and 38.39 mg/g, respectively. 
Those in P. quinquefolius were 13.25 and 14.93 mg/g, 
respectively.  
Peak patterns between radix and rhizome of P. ginseng 
and P. quinquefolius was not significantly different. But it 
was quite different between radix and rhizome of wild P. 
vii 
 
vietnamensis. Radix contains higher amount of 
ginsenosides in particular due to variation in 
protopanaxatriol type ginsenoside contents. 
 
Keywords: Panax ginseng, Panax vietnamensis, Panax 
quenquifolius, ginsenoside, quality control, HPLC analysis. 
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For many thousand years, mankind has been using various 
plants as nutrient, beverage, cosmetics, dye and medicine 
to maintain health and to improve quality of life. Ginseng is 
a group of plants belonging to the genus Panax, consisting 
of several species of slow-growing perennials with fleshy 
roots, in the family Araliaceae. Ginseng grows in Korea, 
China, Japan, Vietnam, and North America and is 
considered to be one of the most important plants in 
herbal medicine, with many health benefits arising from 
consumption of the rootand its extractives. Resembling at 
times a human body, ginseng roots have been considered 
to have wide ranging effects, benefiting the body as a 
whole. Ginseng has perhaps the longest continuous history 
of usage of any healing herb. Sometimes referred to as the 
"root of heaven," ginseng is a good example of an ancient 
herb that Western medicine is just beginning to study and 
understand [1]. Ginseng is characterized by the presence 
of ginsenosides and gintonin. The botanical/genus name 
Panax means "all-heal" in Greek, sharing the same origin 
as "panacea" was applied to this genus because Linnaeus 
was aware of its wide use in Chinese medicine as a muscle 
relaxant. However, true ginseng plants belong only to the 
Panax genus [2]. There are 12 recognized species and 
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two infraspecific taxa of ginseng, depending on the method 
of classification. The following table contains all known 
species of ginseng (Table 1). 
Table 1. Sepcies names of Panax genus  
 
Name Rank 
1 Panax bipinnatifidus Seem. Species 
2 Panax ginseng C.A.Meyer Species 
3 Panax japonicus (T. Nees) C.A. Meyer Species 
4 Panax notoginseng (Burkill) F.H. Chen Species 
5 Panax pseudoginseng Wall. Species 
6 Panax quenquifolius L. Species 
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Panax stipuleanatus H.T. Tsai & K.M. 
Feng 
Species 
9 Panax trifolius L. Species 
10 Panax vietnamensis Ha & Grushv. Species 
11 Panax wangianus S.C. Sun Species 
12 Panax zingiberensis C.Y. Wu & Feng Species 
13 Panax bipinnatifidus var. angustifolius Infraspecific taxon 
14 Panax bipinnatifidus var. bipinnatifidus Infraspecific taxon 
 
Today, herbalists and physicians in the western world use 
ginseng to treat everything from fatigue to hypertension. 
Its most widely accepted and well-documented use is tied 
to its adaptogenic effects–its ability to enhance the body’
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s overall resistance to physical stress. This may include 
everything from increasing one’s stamina to withstanding 
cold temperatures. Most pharmacological actions of 
ginseng are attributed to ginsenosides,   the major and 
bioactive constituents [3-5]. 
With the development of modern chromatography, there 
are many ginsenoisdes identified from ginseng up to date 
[5,6].On the other hand, ginseng and ginsenoisdes have 
been found to exhibit multiple pharmacological activities 
via different mechanisms and pathways in vitro, in vivo, 
and clinical models [4, 5,7].Having been well documented, 
there are hundreds of research papers as well as 
extensive reviews spotlighted on individual topics, that is, 
cardiovascular [8,9 ], central nervous [10], and immune 
systems [11,12]. Scientifically proven pharmacological 
effects of Panax ginseng are as follows: Efficacy of 
improving cerebral functions [13-17]. Efficacy of 
relieving pain [18]; Efficacy of preventing cancer and 
activate antitumor immunity [19-20]; Efficacy of 
inhibiting cancer cell growth [21.22]; Efficacy of 
increasing immunization functions [23,24]; Anti-diabetic 
efficacy [25-34]; Efficacy of improving liver functions 
[35-40]; Efficacy of adjusting blood pressure [41-43]; 
Efficacy of anti-fatigue and anti-stress [44-48]; 
Efficacy of improving female climacteric disorder [49]; 
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Efficacy of improving male sexual dysfunctions [50-54]; 
Efficacy of inhibiting AIDS virus (HIV) growth [55-58]; 
Efficacy of anti-oxidation and anti-aging activity [59-
66]. 
Ginseng saponins were isolated from the root of Panax 
ginseng and identified their structure in 1963 by Shibata 
et.al. [67], Shibata et.al [68], Shibata et.al [69] these 
saponins were called ginsenosides. Today, approximately 
200 substances, such as ginsenosides, polysaccharides, 
polyacetylenes, peptides and amino acids, have been 
isolated from Panax ginseng [12], and more than 100 
substances have been isolated from Panax quinquifolius 
and Panax notoginseng. Among the substances isolated 
from ginseng, the major and most unique components are 
the ginsenosides, which can be classified into 20S-
protopanaxadiol-type (PPD) or 20S-protopanaxatriol-
type (PPT)[70]. Dammarane-type ginsenosides are 
classified into protopanaxadiol and protopanaxatriol types. 
The protopanaxadiol-type has sugar moieties attached to 
OH at C-3 and/or C-20, and the protopanaxatriol-type 
has sugar moieties attached to OHat C-3, C-6, and/or C-
20. The ocotillol-type has a five membered epoxy ring at 
C-20, and the oleanane-type has modified C-20 side 
chain. Chemically, several differences exist among P. 
ginseng, P. quinquifolius, and P. notoginseng. An important 
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parameter used for differentiation is the presence of the 
ginsenoside Rf in Panax ginseng and notoginseng, the 
pseudo ginsenoside F11 in P. quinquifolius [5] and the 
notoginsenoside R1 in P. ginseng and notoginseng. 
Vietnamese ginseng contains not only protopanaxadiol 
(PPD) and protopanaxatriol (PPT) saponins such as 
ginsenoside Rb1, Rd, Re, Rg1, but also ocotillol saponins, 
such as majonoside R1, R2 (in high yield), and vina-
ginsenoside R1 and R2 [71-79]. Majonoside R2 
constitutes >5% of the dried weight of VG [72]. 
Figure 1 shows the full structure information for the PPD, 












































Figure 1. Structures four compounds classified into the 
protopanaxadiol (PPD), protopanaxatriol (PPT), octillol 




Since the first research on P. ginseng polysaccharide 
reported by Ovodov and Solov’eva [76], there were total 
35 polysaccharides identified from the leaves, roots and 
fruits of P. ginseng up to date. Out of these 
polysaccharides, 16 ones came from the leaves, 18 ones 
from the roots and one from the fruits of P. ginseng. 
Flavonoids and polyacetylenes, such as kaempferol, 
trifolin and panasenoside, were also isolated from the 
roots of P. ginseng. Matsunaga et al. [77] isolated 
polyacetylenes, panaxynol, and panaxydol. Iwabuchi et al. 
[78] isolated two sesquierpene alcohols, pansinsanol A 
and panasinsanol B (Figure 2). Sesquiterpene 
hydrocarbons, α-panasinene, β-panasinsene, α-
neoclovene, and β-panasinsene (Figure 2) were also 
isolated fromthe rootlet. Furthermore, two new sesquitene 
alcohols, ginsenol and senecrassidiol, were found [79,80]. 
In addition, ginsenoynes A, B, C, D, E, F, G, H, I, J, and K 
have been reported. 
Many kinds of polysaccharides were also isolated from P. 
quinquifolius. Immunomodulating glycans, such as water-
soluble COLD-FX (CVT-E002), were isolated from the 
roots of P. quinquifolius [81]. These glycans are poly 
furanosyl-pyranosylsaccharides. Hypoglycemic glycans, 
such as quinquefolans A, B, and C, were isolated from the 
roots of P. quinquifolius [82]. 
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Polyacetylenes, such as polyacetylene PQ-1, PQ- 2, PQ-
3, panaxynol, panaxydol, and 1,8-heptadecadiene-4,6-
diyne-3,10-diol (Figure 3), were isolated from the roots 
of P. quinquifolius [83-85]. Nakamura et al. [86] isolated 
three flavonoids and 3 flavonoid glycosides, kaempferol 
3-O-β-D-sophoroside-7-O-α-Lrhamnopyranoside, 
kaempferol-O-(2,3-di-E-p-coumaroyl-α-
Lrhamnopyranoside), and kaempferol-3-O-α -L-
rhamnopyranoside. Sanchinan-A (1.5×106), PF3111, 
PF3112, PBGA11, and PBGA12 were isolated from 
notoginseng [87]. 
Choi et al. [88] isolated the β-amyloid-induced 
neurotoxicity-ameliorating constituent, quercetin-3-β-
xylopyranosyl-β-D-galactopyranoside, from the root of 




galactopyranoside from the leaves of P. notoginseng 
(Figure 4.). Liu et al. [90] isolated polyacetylene 
compounds, and Chan et al. [91] isolated trilinolein from 
the roots of P. notoginseng. 
Five polyacetylenes have been isolated from notoginseng: 
panaxytriol [92], panaxynol, panaxydol [93], notoginsenic 
acid b-sophoroside, and 10-hydroxydeca-4,6-diynoic 
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acid 10-O-b-D-glucopyranosyl (1 fi 2)-b-
Dglucopyranoside [94]. Some of them have shown anti-
tumor effects [77,95]. Several phytosterols, β-sitosterol, 
daucosterol [96]and stigma sterols, betulin, lupeol and 
calenduladiol [97]have been isolated from notoginseng 
(Figure 5). Phytosterols areplant-derived compounds that 
are similar in structureand function to cholesterol. They 
have properties forreducing blood cholesterol levels, and 
other beneficial effects for the cardiovascular system 
[98].Two flavonoids were isolated from 
notoginseng:quercetin [96] and quercetin-3-O-
sophoroside [99].Flavonoids are plant phenolic compounds 


















































Figure 2. Sesquiterpene alcohols and hydrocarbons 











































































































































Figure 5. Phytosterols isolated from Panax species 
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The most important bioactive components of ginseng are 
ginsenosides, polyacetylenes, polysaccharides, alkaloide, 
and phenolic compounds [101]. The ginsenoside is one of 
the most important secondary metabolites in ginseng and 
various pharmacological activities. Ginsenoside has 
glucosyl moiety at carbon-3, -6, and -20, which can be 
readily converted by acid treatment and heat processing 
[102,103]. Therefore, many researcher have studies the 
aimed at converting major ginsenosides to the more active 
minor ginsenosides [104-107]. Steaming process is 
known to induce a structural change of ginsenoside and to 
enhance the biological activities of ginseng [108-110]. 
Hwang I.G. et al (2010) suggested that thermal processed 
Korean ginseng using water as soaking solvent is 
efficiency for conversion of anticancer ginsenoside, such 
as Rg3(S), Rg3(R), Rk1, and Rg5, from other saponins 
[111]. 
The root of P. ginsengis steamed and dried to prepare red 
ginseng, while the peeled roots dried without steaming are 
designated as white ginseng. 
The commercially available ginseng roots are classified 
into two forms, red and white ginsengs. It was reported 
that all of the saponins found in white 
ginseng were isolated in similar yields from red ginseng, 
while some partly deglycosylated saponins such as 
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ginsenosides Rh1, Rh2 and Rg3 are obtained from red 
ginseng as artifacts produced during steaming [112]. In 
addition, two minor saponins were also isolated only from 
red ginseng, two being designated as ginsenosides Rs1 
and Rs2 [113]. 
Park et.al., demonstrated the cytotoxicity of dammarane 
type glycosides from steam-processed P. ginseng—
namely Rg3, Rg5, Rk1, Rs4, and Rs5 [114]. “Sun 
Ginseng” (high-pressure steam-processed P. ginseng) 
claimed the treatment to be beneficial in improving quality 
of life in cancer patients, mainly those suffering from 
gynecologic or hepatobiliary cancer[115]. Choi P. et al., 
(2015) developed a novel ginseng extract by microwave-
assisted processing. This novel extract exhibits increased 
content of ginsenosides Rg3, Rg5 and Rk1[116]. Recently , 
same research group has investigated the protective 
effects of microwave-processed ginseng and its active as 
yet unidentified ginsenosides against cisplatin-induces 
nephrotoxicity in vitro and in vivo [117]. Kang K.S et al, 
(2010) identified the effects of heat processed giseng ant 
its active component 20(S)-Rg3 on the progression of 
renal damage in type 2 diabetic rats [118]. American red 
ginseng, which was treated by the steam-heat-treatment, 
showed the higher levels of radical scavenging activity 
(DPPH and superoxide anion), inhibited lipid peroxidation 
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and increased the activity of antioxidant enzymes [119]. 
The important constituents in steamed American ginseng 
include several groups of epimers or geometric isomers, 
namely ginsenosides 20(S)/20(R)-Rg2, 20(S)/20(R)-
Rh1, 20(S)/20(R)-Rg3, Rk3  Rh4, Rk1 and Rg5, 
accounting fro over 90% of total ginsenoside content 
[120]. Steamed P. quinquifoliushas more potent activity 
than white ginseng on human cancer cells [121,122]. 
Steamed ginseng berry extract inhibited colorectal cancer 
growth both in vitro and in vivo [123]. Enhanced 
anticancer potential results from chemical degradation and 
conversion of the original saponins to new compounds 
during the steaming process [121,124]. Because of higher 
total ginsenoside concentration, American ginseng had 
stronger anticancer potential than Asian ginseng [125]  
Steaming of P. notoginsengmay change its composition 
[126-129] and alter its biological activities 
[130,131].Toh D. F. et al, (2011) investigate the effects 
of steaming on the chemical profile of raw P. 
notoginsengand the effects ofsteaming duration on anti-
proliferative activities of P.notoginsengin three liver 
cancer cell lines[132]. 
P. notoginseng has been shown to have anticancer activity 
[133,134] and steaming it can increase its anticancer 
activity [134]Sun S. et al. (2010)analysed the influence of 
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different steaming temperatures and duration on changes 
in saponin content of notoginseng root and to correlate the 
observed changes to antiproliferative activities in SW-
480 human colorectal cancer cells[135]. 
Le T.H.V. et al (2014) reported that steaming P. 
vietnamensis at 120° C induces the modification of 
saponin constituents and enhancement of its 
biologicalactivity [136]. Resently they continue their 
study on processed P. vietnamensis, the processing 
temperature at 105_C for P. vietnamensis was studied on 
the saponins composition and antiproliferative 
activity[137]. 
Orally administered ginsenosides are very hard to 
breakdown by gastric juices or liver enzymes. However, 
ginsenosdeis are metobilized by intestinal bacteria and 
then these metabolites are absorbed from intestine. Many 
kinds of bacteria including Prevotella oris [138], 
Eubacterium A-44 [139], Bifidobacterium K 506 [140], 
Bacteroides JY6 [141], and Fusobac- terium K-60 [141] 
seem to cooperatively metabolize ginsenosides. 
Fermented Red Ginseng was developed utilizing specific 
microorganism’s fermentation to increase absorption rate 
of ginsenoside and standardize the effect of ginsenoside 
[142]. By fermenting ginseng, glycoside ginsenoside is 
converted into non glycoside ginsenoside. In other words, 
１８ 
 
glucose, attached into saponin, is metabolized by bifidus 
bacteria and converted into small sized ginsenoside. The 
fermented ginseng contains high concentration of 
Compound K, PPD, PPT and ginsenosides with enhanced 
biological activities such as Rh1, Rh2, Rg5 and Rk1. So 
absorption rate in the body is high and it is expected to 
maximize its efficiency in pharmacology [144]. Cho, H. J 
et al. (2010) has screened edible Lactobacillus species for 
their potential in metabolizing ginsenoides from red 
ginseng[145]. A recently isolated strain, L. plantarum M-
2, that is food-grade, was used for the microbial 
conversion of ginsenosides in red ginseng powder [146]. 
Therefore, to utilize the beneficial properties of 
ginsenosides metabolitesusing food-compatible 
microorganisms, this research group investigated changes 
in total sugars, uronic acid,polyphenols and ginsenoside 
metabolites during fermentation by L. plantarum M-2. 
Also they investigated the anti-metastasis and 
immunological activities of fermented red ginseng in 
animal and human subjects [146,147] indicate that L. 
plantarum M1 is a very useful tool in the structure 
modification and metabolism study of ginseng, as well as 
for the preparation of minor ginsenosides and intestinal 
bacterial metabolites from ginseng powder, which possess 
both selectivity and efficiency. 
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Administration of an extract of the fermented Korean red 
ginseng appeared to protect liver, kidneys, heart and lungs 
of aged rats against oxidative stress by reducing the 
intensity of lipid peroxidation and by enhancing the 
activities of enzymatic and non-enzymatic antioxidant 
[148]. 
Compound K (Figure 6) is one of the major metabolites 
produced (149-152) and has been proposed as the most 
bioavailable metabolite produced from colonic 
fermentation [151]. Many different schemes have been 
reported to produce compound K. Compound K has been 
produced utilizing fungal biotransformation with 
Paecilomyces bainiersp. 229 [153]. Thermo-stable β-
glycosides from Sulfolobus solfataricushas been reported 
to be able to hydrolyze ginsenosides and biotrans-form 
them into compound K at an optimal pH of 5.5 from a 
ginseng extract [154]. Conversion of both Rb1 and Rb2 to 
Ginsenoside Rd is one route to the production of 
compound K [154].Compound K produced by microbial 
transformation of commercial obtained ginsenoside extract 
with Aspergillus niger were found to inhibit the growth of 
a variety of cultured cells including melanoma (B16-B6, 
LC5012.7 μM), hepatocarcinoma (Hep-G2, LC50 11.4 
μM), myeloid leuke-mia (K562, LC50 8.5 μM) and lung 
carcinoma (95-D, LC50 9.7 μM) cells [155]. In human 
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malignant astrocytoma cells, 13 ginsenosides and 
metabolites were screened and compound K and Rh2 were 
identified to induce apoptotic cell death by activating the 
caspases, p38, and MAPK while not affecting the growth 
of primary astrocytes [156]. The effects were magnified 
when combined with a Fas ligand which is part of the 







Figure 6. Compound K 
Due to the fact that Ginseng is a very popular 
phytomedicine used all around the world, a huge quantity 
of work has been carried out during the last 40 years in 
order to develop analytical methods for the identification, 
quantification and quality control of ginsenosides in raw 
plant materials, extracts and marketed products [157, 
158]. TLC is a very common technique for the fingerprint 
analysis of plant material and extract due to its easiness 
of use, low cost and versatility. Asian and American 
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ginseng can be discriminated for their ginsenosides 
composition by two-dimensional TLC [160]. With the 
introduction of densitometry, TLC has become also a 
useful tool for the quantitative analysis: Ginsenosides of P. 
ginseng roots and preparations can be quantified using 
HPTLC Silica gel F254 [161] 
HPLC is fast, sensitive and can be applied to non-volatile 
and thermally labile compounds. Another advantage is 
versatility due to the possibility of using different 
detection techniques such as an ultraviolet detector 
(UVD), evaporative light scattering detector (ELSD), 
charged aerosol detection (CAD), fluorescence detector 
(FLD), pulsed amperometric detector (PAD), and a mass 
spectrometer. Most HPLC applications in ginseng analysis 
over the past 5 years have involved the quantitation of 
ginsenosides or related projects [162]. 
Among the different detection techniques of ginsenoside 
analysis, the UV is the most employed detector found in 
phytochemical laboratories. Because of the weak UV 
absorption of ginsenosides, their detection is usually 
achieved at 198–205 nm. The great majority of the 
literature methods use C18 columns with water or 
phosphate buffers and acetonitrile mixtures as solvent 
system either in isocratic or in gradient elution mode 
[163-170]. The concentration of the phosphate buffer 
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has been shown to be important in order to obtain 
separation of twelve ginsenosides in white P. ginseng 
extracts [171]. The main problems encountered in 
performing HPLC-UV analyses of ginseng are the high 
level of baseline noise and the poor sensitivity due to the 
weak UV absorption of ginsenosides. This feature also 
limits the choice of solvents and mobile-phase modifiers 
for improved separation. ELSD is a mass detector which 
measures the scattered light generated by the non-
volatile particles of analyte produced by the nebulization 
into droplets of the LC effluent. The signal intensity is 
related to the concentration of the solute in the effluent 
but not its chemical identity. ELSD is a universal, non-
specific detector which can provide a stable baseline even 
with gradient elution. Furthermore, many volatile mobile 
phase mofidiers are available to obtain better resolution 
and selectivity [157,172]. Park M.K et al. was the first to 
use ELSD to quaintify ginsenosides on an amino-bonded 
column [173]. Yun BS et al. the same research group 
developed a new HPLC-ELSD method for the 
determination of less polar ginsenosides in processed 
Panax ginseng [174]. Since then, ELSD has been 
consideredthe standard choice for ginsenoside analysis. 
The HPLC-ELSD method has primarily been used for the 
simultaneous quantitation of various ginsenosides from 
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Panax species or transformed ginseng preparations [175-
179], and a principal component analysis of HPLC-ELSD 
chromatograms has been used to discriminate the 
geographic origins of P. ginseng roots [180]. 
CAD was developed as an alternative to ELSD to detect 
poor UV-responsive analytes. CAD is a mass-selective 
detector for non-volatile compounds, and its major 
advantages over ELSD are enhanced sensitivity and 
reproducibility. Using an HPLC-CAD system, Bai et al. 
[181] and Wang et al. [182] simultaneously quantified 
ginsenosides in P. ginseng and P. notoginseng. 
Fluorescence is one of the most sensitive detection 
methods for HPLC analyses. A HPLC method using 
photoreduction fluorescence detection was described for 
the analysis of ginsenosides Rb1, Rb2, Re, Rd and Rg1 in 
P. ginseng and P. notoginseng [183,184]. A novel 
precolumn derivatization method for the quantitative 
determination of ginsenosides Rb1 and Rg1 by HPLC with 
fluorescence detection.was developed by D. Shangguan et 
al,[185]. PAD is a less popular HPLC detector in ginseng 
analysis. It is an electrochemical detector that measures 
the positive potential produced by sample oxidation on a 
gold electrode, lending itself to carbohydrate or 
polyalcohol quantitation coupled with high-performance 
anion-exchange chromatography (HPAEC). Park MK et al. 
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(1994) was the first to develop an ion chromatography- 
PAD method for ginsenoside analysis [186]. Joo et al. 
[187] simultaneously determined two Amadori compounds 
in Korean red ginseng and plasma samples from rats 
treated with red ginseng extract using HPAEC-PAD. 
Kwon et al. [188] and Kwon et al. [189] developed a 
method for the highly sensitive quantitation of 
ginsenosides using reversed-phase HPLC-PAD under 
alkaline conditions. UPLC, an advanced type of HPLC, has 
emerged as a powerful tool in many analytical laboratories 
to profile phytochemicals in crude plant extracts [190]. 
Dan et al. [191] and Xie et al. [192] developed an UPLC-
electrospray (ESI)-MS method to determine saponins in 
P. notoginseng, and an UPLC time- of-flight (TOF)-MS 
for metabolomics profiling of several Panax plants. GC is a 
high-resolution and, environment friendly separation 
technique that avoids the use of toxic solvents. Volatile 
compounds in ginseng have easily been determined by GC 
with applicable detection technologies, such as MS. Xie et 
al. [193] determined volatile oils in the root of P. ginseng 
at different ages. Abd El-Aty et al. [194] characterized 
volatile flavor compounds with GC-MS and determined 
their content in white and red ginseng. Liu et al. [195] 
determined polyacetylenes in Panax species using GC-MS 
method. MS-based applications have occupied a major 
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portion of ginseng analyses in recent years and are 
leading the trend in analytical methods. Because of its 
powerful identification and quantitation capabilities, MS is 
a versatile analyzer for the analysis of non-volatile 
molecules in ginseng, such as ginsenosides and their 
metabolites in biological systems [157,172,196]. Various 
types of mass analyzers are used for ginseng analysis: 
quadrupole (Q), ion trap (IT), TOF, and Fourier transform 
ion cyclotron resonance (FT-ICR) [172]. Moreover, 
multi-stage MS combines different mass analyzer designs 
that give advanced structural information, sensitivity, 
specificity, and versatility [172]. Triple quadrupole (QqQ), 
Q-IT, Q-TOF, or IT-TOF are used for ginseng analysis. 
Quadrupole is the simplest and least expensive mass 
analyzer. TOF analyzer measures accurate mass with high 
resolution and a full-scan mass range, thereby making it 
suitable for the identification of unknown metabolites.A 
variety of extraction, purification, and analysis 
procedureshave been utilized to obtain and quantify 
ginsenosides fromleaves [197,198], berries [199], or 
most commonly, roots [200-203]. Most extraction 
procedures use methanol or ethanol [201,202] as solvents, 
either pure or as an aqueous solution [201], and solvents 
often accompanied by heating, refluxing, or sonication[200-
205]. Subsequent purification can include cloud-point 
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extraction/salting out [206], oxidative cleavage and 
trimethylsilylation [204], solid-phase extraction 
[206,207,208], or additional extraction with diethyl 
ether/n-butanol [163,197, 209, 201-213].Undoubtedly, 
ginseng saponin is the main constituents of ginseng and 
they are used as markers for the quality control of 
ginseng. In Korean Pharmacopeia (KP) and Japanese 
Pharmacopeia (JP), ginseng is defined as the root of P. 
ginseng which contains not less than 0.10% of ginsenoside 
Rg1 and not less than 0.20% of ginsenoside Rb1(Table 2 
and Table 3). In Chinese Pharmacopeia (CP), ginseng 
should contain not less than 0.30% of Rg1 + Re and not 
less than 0.20% of Rb1.This kind of standard is 
appropriate for the quality control of white ginseng and its 
powder. However, some ginseng products are difficult to 
apply this standard as ginseng saponin is not stable in 
some environment. It is well known that most ginsenoside 
lose a part of its sugar moiety and transformed to less 
polar ginsenoside especially under the heat, in acidic 
condition, or by fermentation. Heating process converts 
the naturally occurring ginsenoside Rb1 and Rg1 into 
artifact ginsenosides such as ginsenoside Rg3, Rg5, Rh1, 
and Rh2, among others. Therefore, ginsenoside Rg1 and 
Rb1, which have been used as quality markers of ginseng, 
do not express the quality of some ginseng products. The 
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analytical methods currently used to detect these two 
compounds not appropriate by several parameters for the 
analysis of processed ginseng: 1) ginsenoside Rg1 and 
Rb1 are just two of several saponins present in ginseng; 2) 
the contents of the two ginsenosides are not necessarily 
proportional to the amount of total saponins; 3) this kind 
of standard is appropriate for the quality control of white 
ginseng and its powder, but does not express the quality 
of some ginseng products; 4) multiple runs or strict 
analytical conditions are needed in the HPLC analysis 
because ginsenoside Rg1 and Re are difficult to separate. 
Considering many kinds of processed ginseng and its 
products were developed recently, it is necessary to 
develop a new standard for the quality control of ginseng 
products. It is generally known that purchasing or isolation 
of ginsenosidesis time, labor, and money consuming. 
Therefore, the goal of this experiment is developing a new 
simplified and inexpensive analytical method for all kinds 
of ginseng products with the using of reference standards 






Table 2. Comparison of Korean Official Compendia for Ginseng 
 
Compendium Items listed Criteria 
Korean Pharmacopeia 
(KP) 
Ginseng Rg1 : ≥ 0.10%, Rb1: ≥ 0.20% 
Red Ginseng Rg1 : ≥ 0.10%, Rb1: ≥ 0.20% 
Korean Herbal 
Pharmacopeia (KHP) 
Ginseng Powder Rg1 : ≥ 0.10%, Rb1: ≥ 0.20% 
Health Functional Food 
Code 
Raw Material for 
Ginseng Health Functional Foods 
Rg1 + Rb1 : 0.8-34 mg/g 
Raw Material for 
Red Ginseng Health Functional Foods 
Rg1 + Rb1 + Rg3: 2.5–34 mg/g 
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Table 3. Comparison of Quality Standards of Ginseng in the World 
 
Country Items Criteria 
Korea (KP) Ginseng / Red Ginseng Rg1 ≥ 0.10%, Rb1≥ 0.20% 
Japan (JP) Ginseng / Red Ginseng Rg1 ≥ 0.10%, Rb1≥ 0.20% 
China (CP) P. ginseng  Leaves Rg1 + Re ≥ 2.25% 
P. ginseng  Roots Rg1 + Re ≥ 0.30%; Rb1 ≥ 0.20% 
Red Ginseng Roots Rg1 + Re ≥ 0.25%; Rb1 ≥ 0.20% 
P. notoginseng  Roots Rg1 + Re + NR1 ≥ 5% 
Saponins from 
P. notoginseng 
NR1≥ 5%; Rg1 ≥ 25%; Re ≥ 2.5%; 
Rb1 ≥ 30%; Rd ≥ 5% 
USA (USP) P. quinquefolius Powder Rg1 + Re + Rb1 + Rc + Rb2 + Rd ≥ 4% 
P. quinquefolius Extract Rg1 + Re + Rb1 + Rc + Rb2 + Rd ≥ 10% 
P. ginseng Rg1 ≥ 0.10%, Rb1≥ 0.20% 
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P. ginseng Extract Rg1 + Re + Rb1 + Rc + Rb2 + Rd ≥ 3% 
EU (EP) Ginseng Rg1 + Rb1 ≥ 0.40% 
CODEX Ginseng Products (Food) Detection of Rb1 






2.1. Materials  
Ginsenosides Rg1, Re, Rb1, Rc, Rb2, Rd, Rg3(S), Rk1 and 
Rg5were isolated in our laboratory from heat processed 
ginseng using open-column chromatography and semi-
preparative liquid chromatography (Figure7).The purity of 
all ginsenosidestandards was determined to be over 99% 
by LC–ELSD analysis. Standard stock solutions were 
prepared in methanol and stored at 4°C before use. 
Working solutions were freshly made by diluting the stock 
solutions with methanol. Notoginsenoside R1 and R2 were 
purchased from Ambo Institute (Daejeon, Korea). 
Majonoside R1, R2, and Vina-ginsenoside R2 were 
provided by the University of Medicine and Pharmacy, Ho 
Chi Minh city, Vietnam. The identity and purity of these 
standards were confirmed by LC-UV-ELSD and LC-MS.  
HPLC-grade methanol, acetonitrile, and water were 




Fresh roots of Panax ginseng were purchased from a local 
market in Seoul, South Korea. 
Wild Panax vietnamensis was collected from Yunnan 
province, China. Wild Panax ginseng and Panax 
quinquefolius were obtained from Manchuria, China and 











































Ext. with n-BuOH (×3) 
Water layer BuOH layer 
Silica gel column 
Chromatography 
Fr.1  Fr.2  Fr.3  Fr.4  Fr.5  











2.2.1. LC-UV  
High-performance liquid chromatographic analysis was 
carried out on a Perkin–Elmer (Waltham, Massachusetts, 
United States) LC Series 200 instrument consisting of an 
LC pump, a UV/VIS detector, a vacuum degasser, and an 
autosampler fitted with a 200 µL sample loop. A C18 
column with a particle size of 5 µm, an inner diameter of 
4.6 mm, and a length of 250 mm was purchased from 
Waters (Mildford, Massachusetts, United States) and used 
at room temperature. 
 
2.2.2. LC-ELSD 
High-performance liquid chromatographic analysis was 
carried out on a Perkin–Elmer (Waltham, Massachusetts, 
United States) LC Series 200 instrument consisting of an 
LC pump, a vacuum degasser, and an autosampler fitted 
with a 200 µL sample loop, and Alltech ELSD 2000 
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(Deerfield, Illinois, United States) was used to quantitate 
ginsenosides in ginseng species. 
2.2.3. LC-Q-TOF-MS  
A Waters ACQUITY UPLC (Massachusetts, United States) 
combined with a ‘micrOTOF-Q II’(Bruker Daltonik Inc. 
Bremen, Germany) mass spectrometer was utilized to 
identify ginsenosides, including unidentified ones. A 
Waters ACQUITY BEH C18 column, 2.1 mm I.D.×100 mm 




2.3. Methods  
2.3.1. Sample preparation of heat treated ginseng and 
Panax ginseng  
Heat-treated ginseng was prepared by steaming P. 
ginseng at 120°C in an autoclave for three hours and 
drying in an oven. White ginseng powder was prepared by 
pulverizing the purchased ginseng roots. Heat-treated 
ginseng powder was prepared in the same fashion. Five 
solvent systems for extraction were prepared: 50, 60, 70, 
80, and 90% (v/v) methanol in water. 
An approximately 1 g of each powder sample was added 
to 30 mL of one of the five solvent systems and sonicated 
at 30-50°C for 15-45 min in a Branson (Danbury, 
Connecticut, United States) 5510 ultrasonic bath. A small 
amount of sodium hydroxide was added to the volumetric 
flask for hydrolysis. The solution was neutralized with 
hydrochloric acid, and the solvent for extraction was 
added until the meniscus rested on the graduation mark. 
The solution was filtered through a syringe filter unit with 
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a pore size of 0.45 µm, purchased from Advantec MFS, Inc. 
(Dublin, California, United States). 
2.3.2. Preparation of standard solution 
Approximately 1 mg of each standard was weighed and 
transferred into a vial, and methanol was added to yield a 
1 g/L stock solution. Then, the stock solution was diluted 
stepwise to yield five standard solutions whose 
concentrations are from 20 to 320 mg/L in a geometric 
fashion. Each standard solution was filtered through a 


























Scheme 2. Proposed method for the sample preparation of ginseng 
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2.3.3. Sample preparation of wild Panax species 
The dried radix and rhizome of three wild Panax species 
(Panax vietnamensis, Panax ginseng, and Panax 
quinquefolius) were pulverized. Dried powder (150 mg) 
was extracted sequentially in 10,10, and 5 mL of methanol 
by sonication for 60 min at 50 °C. After extraction, 
supernatants from centrifugation (3,000 rpm, 5 min) were 
collected in volumetric flasks and diluted to 25 mL. The 
collected solution was concentrated and reconstituted as 
appropriate, then filtered with a 0.2 µm syringe filter prior 
to injection. 
2.4. Chromatographic conditions 
2.4.1. LC-UV analytical condition 
The eluent was initially held at 21% acetonitrile for 10 
min, then ramped to 24% acetonitrile over 15 min, ramped 
to 33% acetonitrile over 5 min, ramped to 37% acetonitrile 
over 12 min, then ramped to 80% acetonitrile over 27 min, 
and finally held for 5 min. The total run time was 74 min, 
which did not include the time for equilibrium; the initial 
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condition was held for 10 min right before each injection. 
The flow rate was set at 1.0 mL/min, and the injection 
volume was 20 µL. The UV/VIS detector was set at 203 
nm. 
2.4.2.LC-ELSD analytical condition 
Chromatographic separation was performed on a Waters 
(Massachusetts, United States)sunfireC18 column, 4.6 mm 
I.D. ×250 mm L, packed with 5 μm particles at 30 °C. 
The mobile phase consisted of water (phase A) and 
acetonitrile (phase B). The flow rate was 1 mL/min 
gradient elution was used as follows: 0-1 min (18% B), 
1-5 min (18-25% B), 5-25 min (25-32% B), 25-29 
min (32% B), 29-40 min (32-38% B), 40-45 min (38-
45% B), 45-46 min (45-100% B), 46-56 min (100% B). 
10 µL of sample solution was injected for analysis. 
ELSD settings were optimized as below: evaporation 
temperature 80 °C, nitrogen gas flow 2.0 L/min, and 





Mobile phase consisted of water with 0.1%formic acid 
(phase A) and acetonitrile with 0.1% formic acid (phase 
B). The flow rate was 0.3 mL/min and the gradient 
condition was as for LC-ELSD analysis. 5 µL of sample 
solutions were analyzed. The ‘ micrOTOF-Q II ’ 
parameters were set as follows: negative ion mode, 
capillary 3.5 kV, nebulizer pressure 1.2 bar, dry gas flow 
rate 8 L/min, and temperature 200 °C. The following ion 
transfer and collision stages were used: funnel 1 RF 400 
Vpp, funnel 2 RF 400 Vpp, hexapole RF 400 Vpp, 
quadrupole ion energy 15 eV, collision energy 10 eV, 
collision RF 400 Vpp, transfer time 100 μs, prepulse 
storage 5 µs. High purity nitrogen and argon were used 
for nebulization and collision, respectively.
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2.5. Optimization of the extraction conditions  
In order to obtain quantitative extraction, variables 
involved in the procedure such as extraction solvents 
(Figure 8),(Figure 9) and temperature were optimized 
(Figure 10). Five different solvent conditions including 50, 
60, 70, 80, and 90% (v/v) methanol in water were tested 
for the efficient extraction of ginsenosides from two 
ginseng samples, White ginseng and heat-processed 
ginseng.  Aqueous methanol solutions were tried as the 
extraction solvent.  As shown in Figures 8 and 9 no 
significant differences were obtained in solvent 
extractions and temperature. It could be seen from Fig. 10 
that 70% aqueous methanol extraction provided high 
extraction yield. Thus 70% aqueous methanol was chosen 














Figure 8. Effects of number of extractions on the extraction. 1) Proposed method 2) Official method (KP) 

























Figure 10. Effects of extraction solvents on the extraction (methanol and water) 
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2.6. Quantification of ginsenosides 
The linearity, regression and linear ranges for 9 
ginsenosides were determined using the developed 
HPLC-UV method. The limit of detection (LOD) and the 
limit of quantification (LOQ) were calculated as measure 
of sensitivity. The LOD and LOQ under the present 
chromatographic conditions were determined on the basis 























3. Results and discussion  
3.1.Optimization by Design of Experiment 
In general usage, design of experiments (DOE) or 
experimental design is the design of any information-
gathering exercises where variation is present, whether 
under the full control of the experimenter or not. [41] 
To study the effects of parameters (extraction time, 
solvent type and temperature) on the extraction of Panax 
ginseng a Box-Behnken design was implemented. [42] 
Thirteen runs were carried out to cover all possible 
combination of the three factors. All runs were randomly 
performed with three replicates. 
The results of design with three factors, extraction time, 
extraction solvent (five levels) and temperature (three 
levels) are given in Figure 11, 12 and 13. 
Generally, ginsenosides can be extracted with a variety of 
solvents but hot water, methanol and ethanol are typically 
used. Methanol extractions tend to extract a greater 
abundance of ginsenosides.  
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The effects of the solvent polarity on the extraction of the 
nine ginsenosides are crucial, temperature is much less 
significant. The optimal condition was 73% CH3OH, 41°C 
(Figure 11). Both temperature and time has a little 
influence on the extraction of ginsenosides. The optimal 
condition was 41°C, 28 min (Figure 12). When the time 
is much less significant, the effects of solvent polarity for 
the extraction of ginsenosides are crucial (Figure 13). 
To this end, nine ginsenosides, Rb1, Rb2, Rc, Rd, Re, Rg1, 
(20S)-Rg3, Rg5, and Rk1, extracted from the two ginseng 
preparations were analyzed by a 74-min chromatographic 
method. Unlike most reported conditions, however, in our 
method, the analytes were eluted at a flow rate of 1 
mL/min and detected by a UV spectrophotometer at 203 
nm, allowing for more universal applicability. While most 
ginsenosides were well separated from one another, the 
resolution between the first two saponins peaks in the 
chromatograms, corresponding to ginsenosideRg1 and Re, 












Figure 13. Effects of Time and Solvents on the Extraction 
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3.2.Quantification of ginsenosides 
 
The calibration curves, the LODs and LOQs for the 
ginsenosides are shown in Table 4. The correlation 
coefficient (R2 ≥ 0.09942) values indicated the 
appropriate correlations between concentrations of 
investigated compounds and their peak areas within test 






















Table 4. Calibration curves, squared correlation coefficients, test ranges, LODs and LOQs of nine 
ginsenosides 
 
Ginsenoside Calibration curve R2 
Test range 
(mg/L) 
LOD (ng) LOQ (ng) 
Rg1 y = 241x + 344 0.9999 20–320 5 17 
Re y = 176x + 311 0.9999 20–320 7 23 
Rb1 y = 333x + 2041 0.9986 20–320 3 9 
Rb2 y = 262x – 73 0.9962 20–320 3 11 
Rc y = 274x + 2719 0.9961 20–320 4 15 
Rd y = 334x + 2044 0.9985 20–320 3 8 
(20S)-Rg3 y = 595x – 1370 0.9980 20–320 1 5 
Rk1 y = 946x + 11327 0.9942 20–320 1 3 




3.3. Optimal extraction conditions 
In this work, the extraction efficiency was represented by 
the total contents of the nine major ginsenosides 
calculated from the HPLC data. Of the nine, relatively 
polar saponins such as ginsenoside Rb1, Rb2, and Rc were 
dominant in both raw and heat-processed ginseng. Thus, 
the extraction efficiency was likely to be principally 
determined by the effects of the solvents on the 
extraction of the three major ginsenosides. 
The optimal solvent for the extraction of polar 
ginsenosides Rb1 and Rg1 was 60% methanol. For both 
raw and heat-processed ginseng (major ginsenosides: 
Rb1, Rg1 and Rg3), the optimal solvent was 70% methanol 
in water. 
Even though ginsenoside Rb1, Rb2, and Rc are dominant, 
heat-processed ginseng contains a substantial amount of 
artifactual saponins including ginsenoside (20S)-Rg3, Rg5, 




Intriguingly, ginsenoside Rg5 and Rk1 were found to be 
best extracted with 80% methanol.  
 
3.4. LC group analysis of nine major ginsenosides in 
ginseng products 
Up to now, most reports concerning quality control of 
ginseng products have been published [39, 40]. But for 
the carrying analysis of ginseng products by mentioned 
above reports [39, 40] a number of many ginsenosides 
are required. It's generally known that purchasing or 
isolation of ginsenosides is costly and time-consuming 
process.  
The purpose of the study was to determine a simplified 
and inexpensivequality control method of ginseng and its 
products by using reference ginsenosides only. 
Firstly all nine ginsenosides were sub categorized into the 
three groups with their reference compounds: where A is 
protopanaxatriol group (PPT), B is protopanaxadiol group 
(PPD) and less polar ginsenosides group is C (Table 5). 
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To calculate of total contents of each group ginsenosides 
Rg1, Rb1 and Rg3 standards were chosen as reference 
compounds, respectively. To obtain the total content of 
each group ginsenosides two factors, molecular weight of 
reference compound and total sum of molar concentrations 
of ginsenosides were used. 
Results showed how the official KP method properly 
works on an example of white ginseng where Rg1 should 
be not less than 0.1mg and the content of Rb1 not less 
0.2mg. When proposed method was applied for the 
analysis of ginsenosides in White ginseng, the composition 
of ginsenosides was sufficient. The content of 
ginsenosides Rg1 and Rb1 were 0.37mgand 1.41mg, 
respectively. It shown that the total content of 
protopanaxatriol and protopanxadiol group 1.23 mg and 
3.91mg, respectively was good enough to validate the 
content of White ginseng. Application of official method for 
the analysis of heat-processed ginseng does not express 
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the quality of product, because the content of Rg1 was 
degraded during steaming process.  
On the contrary, application of the proposed method’s 
results showed good enough total content of each group 
ginsenosides. The (A) protopanaxatriol group 0.38 mg, 
the (B) protopanaxadiol group 3.16 mg and (C) less polar 
ginsenosides group 1.90 mg, respectively. 
According to the results of this experiment we can see the 
effectiveness of the proposed method for the analysis of 






























Figure 13. Representative LC-UV chromatograms of raw ginseng and heat-processed ginseng extracted 
with 70% aqueous methanol. (a) Raw ginseng (b) heat-processed ginseng. 1, Re; 2. Rg1; 3, Rb1; 4, Rc;  
































Table 5. Reference compounds of group ginsenosides 
Group Ginsenosides Note Reference compound 
(A) Re, Rg1 Polar PPTs Rg1 
(B) Rb1, Rb2, Rc, Rd Polar PPDs Rb1 
(C) Rg3(R,S), Rg5, Rk1 Less polar artifacts Rg3 
Protopanaxatriol (PPT) type 
Protopanaxadiol (PPD) type 
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4.1. Identification of ginsenosides in wild 
Panaxvietnamensis. 
A total of 17 ginsenosides were detected by LC-ELSD 
(Figure 14). Due to the identical gradient conditions 
(column size, flow rate, and system capacity) in LC-Q-
TOF-MS, retention times were similar to LC-ELSD, as 
confirmed using ginsenoside standards. A total of 11 
ginsenosides were identified using standards: 
notoginsenoside R1, majonoside R1, ginsenoside Rg1, 
ginsenoside Re, majonoside R2, vina-ginsenoside R2, 
notoginsenoside R2, ginsenoside Rb1, ginsenosideRc, 
ginsenoside Rb2, and ginsenoside Rd. To identify six other 
unidentified metabolites, m/z of [M-H] - and fragment 
ions were measured by LC-Q-TOF-MS and compared to 
literature values [43-46]. Two ginsenosides 
(quinquenoside R1 and gypenoside XVII) were tentatively 
identified. The m/z value of the aglycone (459.4; 
protopanaxadiol) supported literature-based identification 


















Figure 14.Representative ELSD chromatograms of wild 
Panaxvietnamensis. 1, Unidentified 1; 2,Notoginsenoside 
R1; 3, Majonoside R1; 4, Ginsenoside Rg1 and Ginsenoside 
Re; 5, Majonoside R2; 6, Unidentified 2; 7, Vina-
ginsenoside R2; 8, Notoginsenoside R2; 9, Ginsenoside 
Rb1; 10, GinsenosideRc; 11, Unidentified 3 
(Quinquenoside R1); 12, Ginsenoside Rb2; 13, 
Ginsenoside Rd; 14, Unidentified 4 (Gypenoside XVII); 15, 
Unidentified 5; 16, Unidentified 6 
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Parent Fragment b 




  Unidentified_1 Radix 
Rhizome 
2 12.8 931.5  931.5 C47H80O18 Notoginsenoside 
R1C 
Radix 














5 15.8 785.4  785.4 C41H70O14 Majonoside R2c Radix 
Rhizome 
6 16.8 799.5 637.4 
475.4 
(PPTe) 
  Unidentified_2 Rhizome 







a Matched with LC-ELSD chromatogram 
b For tentative identification, unidentified metabolites were analyzed by MS/MS 
c Identified against standard 
8 28.4 769.4  769.4 C41H70O13 Notoginsenoside R2
c
 Radix 
















12 39.4 1077.5  1077.5 C53H90O22 Ginsenoside Rb2c Radix 














15 48.8 N.C. g 
N.C. g 
   Unidentified_5 
Unidentified_6 
Rhizome 
       Rhizome 
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d Identified by comparison with literature values  
e Measured m/z of protopanaxatriol (PPT) 
f Measured m/z of protopanaxadiol (PPD) 
g No connection between LC-ELSD chromatogram and LC-QToF-MS chromatogram 
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4.2. Quantification of ginsenosides in wild 
Panaxvietnamensis 
Ocotillol type ginsenosides, commonly contained in P. 
vietnamensis varieties, are unsuited to UV detection due 
to the absence of chromophores (Figure 1), so an ELSD 
detector was used for quantification. Seventeen 
ginsenosides were divided into two groups in order of 
elution. Ginsenoside Rg1 and Rb1 were chosen as 
representative standards for the indirect quantification of 
the two groups. Linearity was evaluated by preparing six 
calibration points ranging from 15 to 500 µg/mL; R2 
values for ginsenosides Rg1 and Rb1 were 0.9977 and 
0.9991, respectively. Thus, both calibration curves 
exhibited linearity in the tested range. 
The ginsenoside contents of Panax vietnamensis radix and 
rhizome are shown in Table 7. When unidentified 
ginsenosides were not considered, notoginsenoside R1, 
notoginsenoside R2, ginsenosideRc, and ginsenoside Rb2 
were not detected in the rhizome, unlike the radix. Total 
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content of identified ginsenosides in the radix and rhizome 
were 111.06 and 84.44 mg/g, respectively. The radix 
contained approximately 31 percent more ginsenoside 
than the rhizome, mainly due to differences in the contents 
of protopanaxatriol type ginsenosides: notoginsenoside R1, 
notoginsenoside R2, ginsenoside Rg1, and ginsenoside Re. 
Differences in the content of protopanaxadiol and ocotillol 
type ginsenosides were smaller than for the 
protopanaxatriol type. Moreover, ocotillol type 
ginsenosides accounted for the highest proportion of 




Table 7. Ginsenosides content of wild Panax 
vietnamensis (n=3) 
 
a Protopanaxadiol (PPT) type 
bProtopanaxadiol (PPD) type 
c Ocotillol type 
dCalculated as the sum, except for unidentified 
ginsenosides 
e Not detected 
No. Compound Content 
Radix Rhizome 
















 32.44±10.72 8.21±3.02 













 10.08±5.26 15.49±3.48 
10 GinsenosideRc
b




N.D.  3.47±0.60 
12 Ginsenoside Rb2
b
 2.01±0.50 N.D. 
13 GinsenosideRd
b





15 Unidentified_5 N.D. 6.01±1.25 















4.3. Comparison of ginsenoside content in radix and 
rhizome of three wild Panax species 
Interestingly, dissimilar peak patterns were observed in 
the radix and rhizome of wild Panax vietnamensis (Figure 
14). Because cultivated ginseng usually does not show 
this difference, we propose that this results from the 
distinctive long rhizome of wild ginseng [47-48]. 
Therefore, two parts of wild Panax ginseng and Panax 
quinquefolius, which also possess long rhizomes, were 
analyzed to determine whether this pattern occurs in other 
wild Panax ginseng species. Chromatograms of wild P. 
ginseng and P. quinquefoliusare shown in Figures 15 and 
16, and the quantitative results are shown in Tables 8 and 
9. The variety and total content of ginsenosides in wild P. 
ginseng and Panax quinquefolius were much smaller than 
in wild Panax vietnamensis. Additionally, ocotillol type 
ginsenosides such as majonoside and vinaginsenoside 
were found exclusively in wild Panax vietnamensis, as 
mentioned above. Differences between the three wild 
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Panax species were summarized to verify our assumption 
about the differences between the parts (Figure 17). The 
difference was not observed in wild P. ginseng or Panax 
quinquefolius, unlike Panax vietnamensis. For confirmation 
of dissimilarity by statistical analysis, the Pearson’ s 
correlation coefficients [49]for the three species were 
calculated. Based on the results in Figure 17, the 
coefficient between radix and rhizome of wild Panax 
vietnamensis was 0.033 (weak correlation), whereas the 
coefficients of wild Panax ginseng and Panax quinquefolius 
were 0.958 and 0.998, respectively, indicating substantial 
positive correlations to wild Panax vietnamensis. In brief, 
the difference in ginsenoside composition between radix 


















Figure 15.Representative ELSD chromatograms of wild 
Panax ginseng. 2, Notoginsenoside R1; 4,Ginsenoside Rg1 
and Ginsenoside Re; 9, Ginsenoside Rb1; 10, Ginsenoside 





















Figure 16.Representative ELSD chromatograms of wild 
Panax quinquefolius. 2, Notoginsenoside R1; 4, 
Ginsenoside Rg1 and Ginsenoside Re; 9, Ginsenoside Rb1; 













 Compound Content mg/g 




4 Ginsenoside Rg1 
+Ginsenoside Re 
2.56±1.24 7.14±1.17 
9 Ginsenoside Rb1 4.91±2.47 17.67±4.77 
10 GinsenosideRc 1.35±1.12 5.03±2.06 
12 Ginsenoside Rb2 0.82±0.53 5.55±2.73 
13 Ginsenoside Rd 0.26±0.09 2.17±0.87 
 Total ginsenosides 10.17±4.77 38.39±11.09 
 









 Compound Content mg/g 




4 Ginsenoside Rg1 
+Ginsenoside Re 
3.85±1.18 4.13±0.70 
9 Ginsenoside Rb1 7.49±3.90 9.39±5.09 
10 GinsenosideRc 0.75±0.42 0.51±0.41 
13 Ginsenoside Rd 0.82±0.64 0.66±0.53 
 Total ginsenosides 13.25±6.13 14.93±6.13 
 
























Figure 17. Comparative radar charts of ginsenosides in 
three different species of wild ginseng. Abundant 
ginsenosides in the radix and rhizome of each species 
were selected for pattern comparisons. (A) P. 
vietnamensis; (B) P. ginseng; (C) P. quinquefolius. Blue, 












5. Conclusion  
In this experiment, a new simplified and inexpensive 
analytical method was developed, which can be suitable 
forall kind of ginseng and its products. 
A comparative analysis was conducted between official 
method (KP) and our proposed method. For quantitative 
analysis of each group ginsenosides reference compounds 
were chosen. 
The results of quantitative analysis of each groups howed 
satisfactory enough content of ginsenosides in both raw 
and heat-treated ginseng samples, which confirms the 
effectiveness of our proposed method.  
Two ginseng preparations, raw and heat-processed 
ginseng, have been quantitatively analyzed under different 
extraction conditions. Apparently, the quantification 
results were dependent on the solvent(s) for extraction. 
When the total contents of nine major ginsenosides were 
evaluated, the optimal conditions for the extraction of 
polar ginsenosides Rb1 and Rg1 were found to be 
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approximately 60% methanol in water. For both raw and 
heat-processed ginseng (major ginsenosides: Rb1, Rg1 
and Rg3), the optimal solvent was 70% aqueous methanol. 
However, 80% methanol in water was the best of the five 
tested solvent systems for the efficient extraction of 
ginsenoside Rg5 and Rk1. The results imply that a less 
polar solvent system might be better for the efficient 
extraction of a ginseng preparation containing a large 
amount of ginsenoside Rg5 and Rk1. We believe that our 
work will help raise the necessity of amending some 
regulations on ginseng products. 
 
LC-ELSD and Q-TOF-MS/MS detected a total of 17 
compounds in wild Panax vietnamensis. 
We determined the concentrations of 17 compounds, 13 of 
which were identified. In Vietnamese ginseng, the major 
ginsenosides were of the ocotillol type. Furthermore, the 
difference in total ginsenoside content between radix and 
rhizome of wild Panax vietnamensis was 31%. This was 
79 
 
caused by differences in protopanaxatriol type 
ginsenosides. We also confirmed that distinct differences 
in peak patterns between radix and rhizome occur only in 
wild Panax vietnamensis, even though all wild ginseng 
species have similar long rhizomes with a round radix. 
This study could be used as a reference for future study 
of the characteristics of Panax vietnamensis.
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인삼사포닌(진세노사이드)은 인삼의 대표적인 활성성분으로 
특히 항당뇨, 항염증 및 항암작용과 관련이 있다. 인삼의 잎이
나 과실, 그리고 특히 뿌리 부분에 포함되어 있는 진세노사이
드를 얻고 이를 정량하기 위하여 다양한 추출, 정제 및 분석 
방법이 사용되어 왔다. 추출법은 일반인삼과 가공인삼 으로부
터 얻어진 진세노사이드의 전처리에 있어서 중요한 과정으로
서, 보편적으로 사용되는 용매추출법에서는 적절한 용매의 사
용, 가열 및 교반등을 통하여 용해도 혹은 용해속도를 증가시
킨다. 
본 연구에서는 일반백삼과 열처리한인삼의 최적추출조건을 결
정하고 각 진세노사이드를 정량하였다. 특히, 추출용매의 극성
이 추출효율에 미치는 영향을 집중적으로 연구하였다. 이때, 
열에의한 변성을 최소화하기 위하여 비교적 낮은온도인 40℃
에서 실험하였다. 
P.ginseng으로부터얻어진백삼과열처리한인삼에함유되어있는아
홉종류의진세노사이드(Rb1, Rb2, Rc, Rd, Re, Rg1, (20S)-
Rg3, Rg5, Rk1)를 추출하기 위하여 다섯 종류의 메탄올-물
혼합액(50, 60, 70, 80, 90% 메탄올)이 사용되었으며 이 혼합
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액들은 서로 다른 추출효율을 보였다. 
최적조건은 백삼과 열처리한인삼 모두에 대하여 60% 메탄올
을용매로 사용할 때인 것으로 나타났다. 다만, 진세노사이드 
Rg5와 Rk1의 효율적인 추출을 위해서는 80% 메탄올이 가장 
좋은 것으로 나타났다. 이로부터 진세노사이드 Rg5와 Rk1을
다량 함유하는 인삼가공품의 경우에는 상대적으로 극성이 낮
은 용매를 사용하여 추출하는 것이 효율적일 것으로 예측 해 
볼 수 있다. 
한편, 아홉 종류의 진세노사이드의 양과 HPLC크로마토그램에
서의 피크면적과의 상관계수의 제곱은 모두 0.994 이상이었으
며, 검출한계는 1 에서 7 ng/mL 사이, 정량한계는 2 에서 23 
ng/mL 사이인 것으로 나타났다. 본 연구에서 제안된 분석방
법은 백삼과 열처리 한 인삼에 함유되어 있는 아홉종류의 진
세노사이드에 성공적으로 적용될 수 있었다. 
 
주요어: Panax ginseng, 열처리인삼, 진세노사이드, 추출, 
HPLC, 자외-가시부흡광검출기 
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